APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Lenalidomide

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

Types
5 mg Capsules · 10 mg Capsules · 15 mg Capsules
Applications
Multiple myeloma (MM) · Myelodysplastic syndromes (MDS)

5 editions21 December 2025

View 5 research editions
$4,950Single user · USD · Market Analysis & ForecastExplore product: LenalidomideCompare research options for Lenalidomide

Pharma & Healthcare

Olanzapine

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Types
Patent · Generics
Applications
Olanzapine Tablets · Others

5 editions22 December 2025

View 5 research editions
$2,950Single user · USD · Industry ResearchExplore product: OlanzapineCompare research options for Olanzapine
APO Research, Inc.